Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Harris

Showing results (351-360 of 398) with videos related to

Pageof 40
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2017
Antibody-based assay discriminates Zika virus infection from other flavivirusesAngel Balmaseda, Karin Stettler, Raquel Medialdea-Carrera, et al.
Plos Neglected Tropical Diseases|February 5, 2021
Developmental outcomes in children exposed to Zika virus in utero from a Brazilian urban slum cohort studyJuan P Aguilar Ticona, Nivison Nery, Joseph B Ladines-Lim, et al.
The Lancet. Infectious Diseases|March 2, 2025
Zika virus vaccines and monoclonal antibodies: a priority agenda for research and developmentJulia T Ostrowsky, Leah C Katzelnick, Nigel Bourne, et al.
EMBO Reports|May 24, 2022
Dengue virus NS1 protein conveys pro-inflammatory signals by docking onto high-density lipoproteinsSouheyla Benfrid, Kyu-Ho Park, Mariano Dellarole, et al.
Medrxiv : the Preprint Server for Health Sciences|August 3, 2021
Epidemics of chikungunya, Zika, and COVID-19 reveal bias in case-based mappingFausto Andres Bustos Carrillo, Brenda Lopez Mercado, Jairo Carey Monterrey, et al.
Science (New York, N.Y.)|July 16, 2016
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infectionKarin Stettler, Martina Beltramello, Diego A Espinosa, et al.
Nature Communications|August 3, 2022
An intranasal ASO therapeutic targeting SARS-CoV-2Chi Zhu, Justin Y Lee, Jia Z Woo, et al.
Science Translational Medicine|October 6, 2021
Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long termLeah C Katzelnick, Jose Victor Zambrana, Douglas Elizondo, et al.
Science (New York, N.Y.)|August 29, 2020
Zika virus infection enhances future risk of severe dengue diseaseLeah C Katzelnick, César Narvaez, Sonia Arguello, et al.
PLOS Global Public Health|March 24, 2023
Health inequities in SARS-CoV-2 infection, seroprevalence, and COVID-19 vaccination: Results from the East Bay COVID-19 studyCameron Adams, Mary Horton, Olivia Solomon, et al.
Pageof 40

Showing results (351-360 of 398) with videos related to

Sort By:
Pageof 40
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2017
Antibody-based assay discriminates Zika virus infection from other flavivirusesAngel Balmaseda, Karin Stettler, Raquel Medialdea-Carrera, et al.
Plos Neglected Tropical Diseases|February 5, 2021
Developmental outcomes in children exposed to Zika virus in utero from a Brazilian urban slum cohort studyJuan P Aguilar Ticona, Nivison Nery, Joseph B Ladines-Lim, et al.
The Lancet. Infectious Diseases|March 2, 2025
Zika virus vaccines and monoclonal antibodies: a priority agenda for research and developmentJulia T Ostrowsky, Leah C Katzelnick, Nigel Bourne, et al.
EMBO Reports|May 24, 2022
Dengue virus NS1 protein conveys pro-inflammatory signals by docking onto high-density lipoproteinsSouheyla Benfrid, Kyu-Ho Park, Mariano Dellarole, et al.
Medrxiv : the Preprint Server for Health Sciences|August 3, 2021
Epidemics of chikungunya, Zika, and COVID-19 reveal bias in case-based mappingFausto Andres Bustos Carrillo, Brenda Lopez Mercado, Jairo Carey Monterrey, et al.
Science (New York, N.Y.)|July 16, 2016
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infectionKarin Stettler, Martina Beltramello, Diego A Espinosa, et al.
Nature Communications|August 3, 2022
An intranasal ASO therapeutic targeting SARS-CoV-2Chi Zhu, Justin Y Lee, Jia Z Woo, et al.
Science Translational Medicine|October 6, 2021
Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long termLeah C Katzelnick, Jose Victor Zambrana, Douglas Elizondo, et al.
Science (New York, N.Y.)|August 29, 2020
Zika virus infection enhances future risk of severe dengue diseaseLeah C Katzelnick, César Narvaez, Sonia Arguello, et al.
PLOS Global Public Health|March 24, 2023
Health inequities in SARS-CoV-2 infection, seroprevalence, and COVID-19 vaccination: Results from the East Bay COVID-19 studyCameron Adams, Mary Horton, Olivia Solomon, et al.
Pageof 40